Sight Sciences, Inc.
Sight Sciences, Inc. (SGHT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SGHT · as of Jun 9, 2026
Key Statistics
Explore Sight Sciences, Inc. Data
sght stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 44.4%
The SGHT analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +115.98% upside from the current price of $4.63.
Competitors & Peers
sght competitorsSGHT
CERS
CVRX
LFCR
MASS
OMIStock Performance
Full HistoryAbout Sight Sciences, Inc.
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its p…
what is sight sciences, inc. · sght stock overview · sight sciences, inc. company profile · who is sight sciences, inc. ceo · sght NASDAQ · sight sciences, inc. headquarters · sight sciences, inc. business segments
About Stock Overview & Key Data
Sight Sciences, Inc. (SGHT) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 15, 2021. As of the latest trading session, SGHT stock price is $4.63, with a market capitalization of $251.9M. The stock has returned +14.04% over the past 12 months and -41.61% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Sight Sciences, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, Sight Sciences, Inc. reported revenue of $77.4M and net income of -$38.4M. For detailed data — including Sight Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Sight Sciences, Inc. (SGHT) stock price is $4.63. The stock is traded on NASDAQ under the ticker symbol SGHT. The 52-week range is $3.11 – $9.24.